Moderna announces a single dose against Covid and the flu by the end of 2023
Moderna announced this Monday that the unique vaccine that would mix a booster against covid and flu could be ready for finals 2023. This was confirmed by the executive president of the American pharmaceutical company, Stephane Bancel, during his speech at the Davos Forum, where he assured that the company is working on this unique solution. In addition, he has indicated that, in the best case, it would be in the fall of 2023 when it would be ready.
Bancel also indicated that the studies for the Respiratory Syncytial Virus (RSV) are in phase III, the final stage of testing in humans and that of the flu should enter this phase. third stage in the second quarter of this year.
Specific drug against Omicron
Also, Moderna Inc.’s vaccine candidate against the variant of the coronavirus Omicron it will enter clinical development in the coming weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday.
“The vaccine is running out…it should be in the clinic in the next few weeks. We hope that in March we will have the data to share with regulators and determine the next steps,” Bancel explained at the conference.